|1.||Kokjohn, Tyler A: 1 article (04/2009)|
|2.||Roher, Alex E: 1 article (04/2009)|
|3.||Schechter, Israel: 1 article (08/2008)|
|4.||Demuth, Hans-Ulrich: 1 article (08/2008)|
|5.||Hook, Gregory: 1 article (08/2008)|
|6.||Hook, Vivian: 1 article (08/2008)|
|7.||Boada, Mercè: 1 article (08/2005)|
|8.||Szabo, Paul: 1 article (08/2005)|
|9.||Unzeta, Mercedes: 1 article (08/2005)|
|10.||del Mar Hernandez, Maria: 1 article (08/2005)|
|2.||Alzheimer Disease (Alzheimer's Disease)
04/01/2009 - "Despite the dispersal of substantial plaque material, vaccination did not constitute even a partial eradication of brain amyloid as water soluble amyloid-beta (Abeta) 40/42 increased in the gray matter compared to sporadic Alzheimer's disease (AD) patients and total brain Abeta levels were not decreased. "
02/01/2000 - "Alzheimer's disease (AD) is characterized by the age-related deposition of beta-amyloid (Abeta) 40/42 peptide aggregates in vulnerable brain regions. "
07/17/2003 - "In contrast, only derivatives bearing a free amino (5d, 5f) or a substituted amino group (6f) at the 7-position of the isocoumarin nucleus, were found weakly active or inactive on alpha-chymotrypsin, trypsin, Caspase-3 and HIV-protease, but prevent gamma-secretase-mediated production of Abeta 40/42 amyloid peptides, which is known to be involved in Alzheimer's disease. "
|1.||Amyloid (Amyloid Fibrils)
|2.||Amyloid Precursor Protein Secretases (beta-Secretase)
|4.||Caspase 3 (Caspase-3)